| 1 |
34963005 | Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. | 2022 Apr 11 |
1 |
| 2 |
35598358 | The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. | 2022 May 19 |
1 |
| 3 |
32458023 | Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways. | 2021 Feb |
2 |
| 4 |
33183422 | Effect of Nano-Platinum on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells via P53 Pathway. | 2021 Feb 1 |
1 |
| 5 |
33375991 | Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations. | 2021 Mar |
3 |
| 6 |
33592864 | Meta-analysis of P53 expression and sensitivity to platinum-based chemotherapy in patients with non-small cell lung cancer. | 2021 Feb 5 |
4 |
| 7 |
33744756 | Oxidative stress cytotoxicity induced by platinum-doped magnesia nanoparticles in cancer cells. | 2021 Jun |
1 |
| 8 |
33827148 | Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer. | 2021 Jun |
1 |
| 9 |
34141624 | Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough? | 2021 |
1 |
| 10 |
34298618 | Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer. | 2021 Jul 7 |
1 |
| 11 |
34647981 | Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib. | 2021 Dec 1 |
2 |
| 12 |
34794242 | The endocytic pathway of Pt nanoclusters and their induced apoptosis of A549 and A549/Cis cells through c-Myc/p53 and Bcl-2/caspase-3 signaling pathways. | 2021 Dec |
1 |
| 13 |
34967559 | Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients. | 2021 Dec 1 |
2 |
| 14 |
32344513 | Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy. | 2020 Apr 24 |
1 |
| 15 |
32382008 | The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. | 2020 May 7 |
1 |
| 16 |
32384200 | p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome. | 2020 Sep |
1 |
| 17 |
32477008 | Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients. | 2020 |
1 |
| 18 |
32504383 | Influence of Tumor Suppressor p53 Functioning on the Expression of Antioxidant System Genes under the Action of Cytotoxic Compounds. | 2020 May |
7 |
| 19 |
32611648 | A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer. | 2020 Sep 15 |
1 |
| 20 |
32749686 | Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. | 2020 Oct 15 |
1 |
| 21 |
32753889 | Sequential Whole Exome Sequencing Reveals Somatic Mutations Associated with Platinum Response in NSCLC. | 2020 |
1 |
| 22 |
32796711 | Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy. | 2020 Aug 11 |
1 |
| 23 |
32910383 | Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy. | 2020 Aug |
1 |
| 24 |
33166854 | Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes. | 2020 |
1 |
| 25 |
30301863 | Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma. | 2019 Jan |
1 |
| 26 |
30339780 | A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53. | 2019 Jan |
1 |
| 27 |
30538112 | Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer. | 2019 Apr 15 |
3 |
| 28 |
30896089 | New insights into germ cell tumor genomics. | 2019 Jul |
1 |
| 29 |
31295913 | Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors. | 2019 Jul 10 |
1 |
| 30 |
31581548 | Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC). | 2019 Oct 1 |
1 |
| 31 |
31798724 | Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases. | 2019 Dec |
5 |
| 32 |
31877751 | Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells. | 2019 Dec 21 |
5 |
| 33 |
29301826 | p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy. | 2018 Mar 15 |
2 |
| 34 |
29307819 | Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells. | 2018 Jan 29 |
1 |
| 35 |
29690507 | Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress. | 2018 Apr 21 |
1 |
| 36 |
29783665 | Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS). | 2018 May 18 |
1 |
| 37 |
30106452 | Integrin β4 reduces DNA damage‑induced p53 activation in colorectal cancer. | 2018 Oct |
6 |
| 38 |
30205260 | Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway. | 2018 Oct 5 |
1 |
| 39 |
30375398 | The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. | 2018 Oct 30 |
1 |
| 40 |
28031409 | Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation. | 2017 Mar |
3 |
| 41 |
28494179 | Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy. | 2017 Jun 3 |
1 |
| 42 |
28730758 | Platinum derivatives: a multidisciplinary approach. | 2017 May-Jun |
1 |
| 43 |
27191893 | Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. | 2016 Jul 26 |
2 |
| 44 |
27313779 | P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer. | 2016 |
3 |
| 45 |
27614750 | Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy. | 2016 Dec |
1 |
| 46 |
27998224 | Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months. | 2016 Dec 20 |
2 |
| 47 |
25263447 | p53 protein aggregation promotes platinum resistance in ovarian cancer. | 2015 Jul |
1 |
| 48 |
25385265 | TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. | 2015 Feb |
2 |
| 49 |
25407898 | Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction. | 2015 Jan 5 |
1 |
| 50 |
25691460 | Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. | 2015 Apr 1 |
1 |